Evaluation of the new LIAISON® CMV IgG, IgM and IgG Avidity II assays

Journal of Clinical Virology

Volumn 72, Issue , 2015, Pages 42-45

  Delforge, M L ^a   Desomberg, L ^a   Montesinos, I ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Chemiluminescence; CMV IgG; CMV IgG avidity; CMV IgM; Cytomegalovirus

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY PRODUCTION; ARTICLE; CHEMOLUMINESCENCE; CYTOMEGALOVIRUS INFECTION; DEVICE COMPARISON; ENZYME IMMUNOASSAY; FALSE POSITIVE RESULT; FOLLOW UP; HEALTH STATUS; HUMAN; IMMUNE SYSTEM; IMMUNOASSAY ANALYZER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROCONVERSION; SERODIAGNOSIS; ANTIBODY AFFINITY; BLOOD; COMPARATIVE STUDY; CYTOMEGALOVIRUS INFECTIONS; EVALUATION STUDY; LABORATORY AUTOMATION; PROCEDURES; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEROLOGY;

ANTIBODY AFFINITY; AUTOMATION, LABORATORY; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEROLOGIC TESTS;

EID: 84946400572     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2015.09.002     Document Type: Article

References (14)

1. Kenneson A., Cannon M. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev. Med. Virol. 2007, 17:253-276.
2. Fowler K.B., Stagno S., Pass R.F. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 2003, 289(February (8)):1008-1011.
3. Adler S.P., Nigro G. Prevention of maternal-fetal transmission of cytomegalovirus. Clin. Infect. Dis. 2013, 57(Suppl. 4):S189-S192.
4. Kotton C.N., Kumar D., Caliendo A.M., Asberg A., Chou S., Danziger-Isakov L., Humar A., on behalf of the Transplantation Society International CMV Consensus Group Updated international consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 2013, 96(August (4)):333-360.
5. Bodéus M., Feyder S., Goubau P. Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women. Clin. Diagn. Virol. 1998, 9(January (1)):9-16.
6. Grangeot-Keros L., Mayaux M.J., Lebon P., Freymuth F., Eugene G., Stricker R., Dussaix E. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J. Infect. Dis. 1997, 175(April (4)):944-946.
7. Prince H.E., Lapé-Nixon M. Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy. Clin. Vaccine Immunol. 2014, 21(October (10)):1377-1384.
8. Lagrou K., Bodeus M., Van Ranst M., Goubau P. Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG and IgG avidity assay. J. Clin. Microbiol. 2009, 47(June (6)):1695-1699.
9. Gentile M., Galli C., Pagnotti P., Di Marco P., Tzantzoglou S., Bellomi F., Ferreri M.L., Selvaggi C., Antonelli G. Measurement of the sensitivity of different commercial assays in the diagnosis of CMV infection in pregnancy. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28(August (8)):977-981.
10. ® cytomegalovirus immunoglobulin IgM and IgG assays. J. Clin. Virol. 2010, 49(November (3)):192-197.
11. De Paschale M., Agrappi C., Manco M.T., Clerici P. Positive predictive value of anti-HCMV IgM as an index of primary infection. J. Virol. Methods 2010, 168(September (1-2)):121-125.
12. Leruez-Ville M., Sellier Y., Salomon L., Stirnemann J., Jacquemard F., Ville Y. Prediction of fetal infection in cases with cytomegalovirus immunoglobulin M in the first trimester of pregnancy: a retrospective cohort. Clin. Infect Dis. 2013, 56:1428-1435.
13. ® cytomegalovirus (CMV) IgG avidity assay: determination of new cut-off values based on the study of kinetics of CMV-IgG maturation. J. Clin. Virol. 2013, 56(February (2)):118-123.
14. Revello M.G., Genini E., Gorini G., Klersy C., Piralla A., Gerna G. Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays. J. Clin. Virol. 2010, 48(August (4)):255-259.